# Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

> **NCT05811247** · PHASE3 · COMPLETED · sponsor: **Apnimed** · enrollment: 660 (actual)

## Conditions studied

- OSA

## Interventions

- **DRUG:** AD109
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05811247
- **Lead sponsor:** Apnimed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-28
- **Primary completion:** 2025-05-07
- **Final completion:** 2025-05-07
- **Target enrollment:** 660 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05811247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05811247, "Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05811247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*